Report Highlights
- The U.S. plastic healthcare packaging market is estimated at 3.8 billion pounds in 2010 and is expected to increase to almost 5 billion pounds by 2015, a 5.6% compound annual growth rate (CAGR).
- Polypropylene is the largest sector at 987 million pounds in 2010. This sector is projected to increase at a compound annual growth rate (CAGR) of 6.3% to 1.3 billion pounds in 2015.
- The PVC market is estimated at 845 million pounds in 2010. By 2015, this sector will reach 1 billion pounds, a compound annual growth rate (CAGR) of 5%.
INTRODUCTION
- Pharmaceutical products, which are defined as drugs in dosage forms that are purchased and consumed by individual patients, and are either prescribed by a licensed medical practitioner or are drugs that do not require a prescription and are purchased by individuals “over the counter” (OTC). These products are usually packaged in containers, blister packs, bags/pouches, etc.
- Medical products, i.e., those used by medical practitioners themselves, in hospitals, clinics, home healthcare operations, etc. Examples are syringes, blood and intravenous solution bags, diagnostic kits, tubing, trays and other similar items.
- Marketing and management personnel in companies that produce, market, and sell all types of plastics, i.e., virgin, specially compounded, and recycled.
- Companies that supply or want to supply equipment and services to plastics processors.
- Financial institutions that provide funding for such facilities, including banks, merchant bankers, venture capitalists, and others.
- Personnel in end-user companies and industries that purchase and use packaging plastics ranging from converters, compounders, and molders to contract packaging companies and healthcare company end-users. Healthcare packagers are a key group of companies who could be interested, as well.
- Personnel in government at many levels. This includes federal officials, primarily at the EPA and FDA, who are involved with protection of national standards regarding public health and safety.
- Trays vs. kits
- Pouches vs. bags
- Closures vs. caps
- Containers vs. bottles
- Closures vs. lidding
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers.
Report Highlights
-
The plastic healthcare packaging market in North America is estimated at 2.5 billion pounds for 2004 and is expected to increase to slightly more than 3.2 billion pounds by 2009, at an average annual growth rate (AAGR) of 5%.
-
Polypropylene represents nearly 28% of the market and will rise at an AAGR of 5.1% to 913 million pounds in 2009.
-
PVC is, and will remain with the second highest share despite efforts to reduce its use. PVC still is regarded as a cost-effective and safe material by the industry.
-
Bottles/vials, tubing/containers, syringes and kits are estimated to be the leading healthcare packaging applications, accounting for more than 83% of total plastic volume in 2004.
Related Reports
Recent Reports
Liquid Crystal Polymers: Global Markets
The global market for liquid crystal polymers is expected to grow from $957.5 million in 2023 to $1.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.1% from 2023 through 2028.
Plastics for Healthcare Packaging
The global market value of plastics for healthcare packaging is expected to grow from $32.1 billion in 2023 and should reach $46.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2023 to 2028.
Medical Plastics: Global Markets
The global market for medical plastics is estimated to increase from $25.6 billion in 2023 to reach $41.2 billion by 2028, at a compound annual growth rate (CAGR) of 10.0% from 2023 through 2028.
EMI/RFI: Materials and Technologies
The global market for EMI/RFI materials and technologies is expected to increase from $7.4 billion in 2023 to $9.2 billion by the end of 2028, with a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2023-2028.
Fluoropolymer Materials: Technologies and Global Markets
The global market volume for fluoropolymer materials is estimated to increase from 346.97 kilotons in 2023 to reach 442.79 kilotons by 2028, at a compound annual growth rate (CAGR) of 5.0% from 2023 through 2028.
Top Trending Reports
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More